Search results
Ozempic maker Novo Nordisk denies flooding market with 'junk' patents after FTC challenge
Quartz· 18 hours agoNovo Nordisk responded today to the U.S. Federal Trade Commission’s (FTC) suggestion that it filed...
Dingyun Zhang Revamps the Adidas Samba Sneaker With Patent Leather and Puffy Paneling
Footwear News via Yahoo News· 18 hours agoHe’s previously reported on streetwear and sneakers at Input and Highsnobiety after beginning his...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
KEYT 3 Santa Barbara· 3 days agoUS challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 3 days agoThe Federal Trade Commission is challenging hundreds of alleged “junk” patent listings filed by...
FTC Challenges 'Bogus' Patents on Ozempic and Other Drugs
MedPage Today· 2 days agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
Cameron Brink Goes Classic in Sleek Leather Shoes for SportsCenter Appearance
Footwear News via Yahoo News· 2 days agoSam Edelman and Nine West offer more accessible options. Shop a Similar Style Steve Madden Evelyn...
FTC Challenges Patents on 20 Brand-Name Drugs as Chair Accuses Them of Inflating Prices with 'Bogus'...
Homenewshere.com· 2 days agoThe Federal Trade Commission challenges patents on 20 brand-name drugs to spur competition, including the blockbuster weight-loss drug Ozempic. The FTC sent warning letters ...
Zomedica Strengthens Market Position with New Patents Issued for its TRUFORMA(R) Diagnostic Platform
Digital Journal· 22 hours ago(NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced the ...
Ozempic and 19 other drugs have 'junk' patents, the FTC says in a new challenge
Quartz· 3 days agoThe U.S. Federal Trade Commission (FTC) announced on Tuesday that it is disputing over 300 patent...
Sandoz reaches agreement with Amgen over patent dispute
Reuters· 3 days agoSwiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S. drugmaker Amgen resolving all patent litigation related to its U.S. denosumab biosimilars.